DUBLIN (AP) _ Prothena Corp. (PRTA) on Wednesday reported a loss of $30.6 million in its third quarter.
On a per-share basis, the Dublin-based company said it had a loss of 77 cents.
The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 68 cents per share.
The drug developer posted revenue of $157,000 in the period, which also did not meet Street forecasts. Three analysts surveyed by Zacks expected $533,000.
Prothena shares have declined 12% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $13.94, a climb of 49% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PRTA at https://www.zacks.com/ap/PRTA